What GLP-1 actually is
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. It tells your brain you're full, slows how fast your stomach empties, and helps your pancreas manage blood sugar. The medications people now call "GLP-1s" — semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) — are engineered to mimic that hormone, but last far longer in the body.
That combination of effects is why the same class of drugs is used both for type 2 diabetes and for weight management: better blood-sugar control and reduced appetite tend to go hand in hand.
From diabetes drug to weight-loss breakthrough
Semaglutide was first approved to help people with type 2 diabetes. Researchers quickly noticed that patients were also losing significant weight, which led to dedicated weight-management versions at higher doses. Tirzepatide followed, acting on two gut hormone receptors instead of one.
In large clinical trials, semaglutide produced average weight loss of roughly 15% of body weight over about 68 weeks, and tirzepatide around 20%, when paired with diet and lifestyle changes. Individual results vary, and the medication is only one part of a broader program.
Why it's prescription-only
GLP-1 medications are powerful and not right for everyone. They require a licensed provider to review your health history, rule out contraindications, set the right starting dose, and monitor for side effects such as nausea. That's why every legitimate program — including the ones we rank — includes a medical review before anything is prescribed.
The bottom line
GLP-1 treatment has changed what's possible in medical weight loss, but it works best as part of a supported program with real clinical oversight. If you're curious whether it's a fit, the safest next step is a quick eligibility check with a licensed provider.